Cargando…
HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689527/ https://www.ncbi.nlm.nih.gov/pubmed/31496768 http://dx.doi.org/10.2147/CEOR.S225177 |
| _version_ | 1783443036199452672 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6689527 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66895272019-09-06 HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum] Clinicoecon Outcomes Res Corrigendum Dove 2019-08-06 /pmc/articles/PMC6689527/ /pubmed/31496768 http://dx.doi.org/10.2147/CEOR.S225177 Text en © 2019 Bretoni et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Corrigendum HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum] |
| title | HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum] |
| title_full | HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum] |
| title_fullStr | HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum] |
| title_full_unstemmed | HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum] |
| title_short | HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum] |
| title_sort | hta and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [corrigendum] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689527/ https://www.ncbi.nlm.nih.gov/pubmed/31496768 http://dx.doi.org/10.2147/CEOR.S225177 |